Cite
Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
MLA
Zhang, Jian, et al. “Short-Term Rosuvastatin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Receiving Moderate or High Volumes of Contrast Media: A Sub-Analysis of the TRACK-D Study.” Chinese Medical Journal, vol. 128, no. 6, Mar. 2015, pp. 784–89. EBSCOhost, https://doi.org/10.4103/0366-6999.152620.
APA
Zhang, J., Li, Y., Tao, G.-Z., Chen, Y.-D., Hu, T.-H., Cao, X.-B., Jing, Q.-M., Wang, X.-Z., Ma, Y.-Y., Wang, G., Liu, H.-W., Wang, B., Xu, K., Li, J., Deng, J., & Han, Y.-L. (2015). Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study. Chinese Medical Journal, 128(6), 784–789. https://doi.org/10.4103/0366-6999.152620
Chicago
Zhang, Jian, Yi Li, Gui-Zhou Tao, Yun-Dai Chen, Tao-Hong Hu, Xue-Bin Cao, Quan-Min Jing, et al. 2015. “Short-Term Rosuvastatin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Receiving Moderate or High Volumes of Contrast Media: A Sub-Analysis of the TRACK-D Study.” Chinese Medical Journal 128 (6): 784–89. doi:10.4103/0366-6999.152620.